EXCEPTIONHYAL® JUMP

ExceptionHYAL® Jump is ROELMI HPC’s breakthrough in joints care. It is based on HATech 2.0® technology and delivers a Full Spectrum of hyaluronans (HA) to joint tissues, matching biological needs and providing a wider range of HA molecular weights. Its Full Spectrum of HA molecular weights addresses to both younger subjects involved in sport activities, from amateurs to athletes, and elderly people suffering from joint osteoarthritis (OA). A RDBPC human trial of proved the clinical efficacy of ExceptionHYAL® Jump. Joint mobility and NSAIDs use were evaluated. The chondroprotective and anti-inflammatory actions, and the enhanced endogenous synthesis of HA exerted by ExceptionHYAL® Jump, led to a significant reduction of pain after only few weeks. The most innovative effect is the reduction of anti-pain drugs intake. Thanks to its strong effect, nearly 17% of subjects stopped NSAIDs treatment, and 70% of them reduced the posology contrary to subjects taking placebo. The unique composition and activity of ExceptionHYAL® Jump are evidenced by the astonishing results in the management of OA, obtained with a short treatment (4 to 8 weeks) and with a low dosage (200mg/day), all features contributing to the high consumer compliance in terms of cost-efficiency and appeal for all ages.